Adherence, persistence and cost–consequence comparison of bimatoprost topical ocular formulations

By Alany Raid G.  

Current Medical Research and Opinion, Vol. 29, Iss. 9, 2013-09 ,pp. : 1187-1189

Informa Healthcare

Access to resources Recommend Favorite

Comparison of adherence and persistence with bimatoprost 0.01% versus bimatoprost 0.03% topical ophthalmic solutions

By Campbell Joanna H.   Schwartz Gail   LaBounty Britni   Kowalski Jonathan   Patel Vaishali D.  

Current Medical Research and Opinion, Vol. 29, Iss. 9, 2013-09 ,pp. : 1201-1209

Informa Healthcare

Access to resources Recommend Favorite

Comparing bimatoprost and travoprost in black Americans

By Noecker Robert J.   Earl Melissa L.   Mundorf Thomas K.   Silverstein Steven M.   Phillips Michael P.  

Current Medical Research and Opinion, Vol. 22, Iss. 11, 2006-11 ,pp. : 2175-2180

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of circadian control of intraocular pressure after a single drop of bimatoprost 0.03% or travoprost 0.004%

By Frenkel Ronald E.   Noecker Robert J.   Craven E. Randy  

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 919-923

Informa Healthcare

Access to resources Recommend Favorite

A Markov modelled pharmacoeconomic analysis of bimatoprost 0.03% in the treatment of glaucoma as an alternative to filtration surgery in Italy

By Christensen Torsten Lundgaard   Poulsen Peter Bo   Holmstrom Stefan   Walt John G.   Vetrugno Michele  

Current Medical Research and Opinion, Vol. 21, Iss. 11, 2005-11 ,pp. : 1837-1844

Informa Healthcare

Access to resources Recommend Favorite